Pure Global AI
ANVISA registration 10338930242Active

17-HYDROXYPROGESTERONE (17-OHP)

ANVISA Registration Number: 10338930242EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAEUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDARisk Class II
Verified
Device names
Technical name
17-HYDROXYPROGESTERONE (17-OHP)
View exact technical-name matches →
PT: 17-HIDROXIPROGESTERONA (17-OHP)
Commercial name
17-OH-Progesterona ELISA
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10338930242
Process Number
25351467559202019
CNPJ
93741726000166
Company information
Registration Holder
EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA
Manufacturer
EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA
Manufacturing Country
Brazil
PT: BRASIL
Dates and status
Publication Date
Dec 10, 2020
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for 17-HYDROXYPROGESTERONE (17-OHP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930242 and manufactured by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.